{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:21:32Z","timestamp":1794540092482,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7212192"],"award-info":[{"award-number":["7212192"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7212192"],"award-info":[{"award-number":["7212192"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7212192"],"award-info":[{"award-number":["7212192"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7212192"],"award-info":[{"award-number":["7212192"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7212192"],"award-info":[{"award-number":["7212192"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7212192"],"award-info":[{"award-number":["7212192"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Ovarian cancer has the highest mortality rate among gynecological malignant tumors, and it preferentially metastasizes to omental tissue, leading to intestinal obstruction and death. scRNA-seq is a powerful technique to reveal tumor heterogeneity. Analyzing omentum metastasis of ovarian cancer at the single-cell level may be more conducive to exploring and understanding omentum metastasis and prognosis of ovarian cancer at the cellular function and genetic levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The omentum metastasis site scRNA-seq data of GSE147082 were acquired from the GEO (Gene Expression Omnibus) database, and single cells were clustered by the Seruat package and annotated by the SingleR package. Cell differentiation trajectories were reconstructed through the monocle package. The ovarian cancer microarray data of GSE132342 were downloaded from GEO and were clustered by using the ConsensusClusterPlus package into omentum metastasis-associated clusters according to the marker genes gained from single-cell differentiation trajectory analysis. The tumor microenvironment (TME) and immune infiltration differences between clusters were analyzed by the estimate and CIBERSORT packages. The expression matrix of genes used to cluster GSE132342 patients was extracted from bulk RNA-seq data of TCGA-OV (The Cancer Genome Atlas ovarian cancer), and least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression were performed to establish an omentum metastasis-associated gene (OMAG) signature. The signature was then tested by GSE132342 data. Finally, the clinicopathological characteristics of TCGA-OV were screened by univariate and multivariate Cox regression analysis to draw the nomogram.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 9885 cells from 6 patients were clustered into 18 cell clusters and annotated into 14 cell types. Reconstruction of differentiation trajectories divided the cells into 5 branches, and a total of 781 cell trajectory-related characteristic genes were obtained. A total of 3769 patients in GSE132342 were subtyped into 3 clusters by 74 cell trajectory-related characteristic genes. Kaplan-Meier (K-M) survival analysis showed that the prognosis of cluster 2 was the worst, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001. The TME analysis showed that the ESTIMATE score and stromal score in cluster 2 were significantly higher than those in the other two clusters, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001. The immune infiltration analysis showed differences in the fraction of 8 immune cells among the 3 clusters, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05. The expression data of 74 genes used for GEO clustering were extracted from 379 patients in TCGA-OV, and combined with survival information, 10 candidates for OMAGs were filtered by LASSO. By using multivariate Cox regression, the 6-OMAGs signature was established as RiskScore\u2009=\u20090.307*TIMP3\u2009+\u20093.516*FBN1\u20130.109*IGKC\u2009+\u20090.209*RPL21\u2009+\u20090.870*UCHL1\u2009+\u20090.365*RARRES1. Taking TCGA-OV as the training set and GSE132342 as the test set, receiver operating characteristic (ROC) curves were drawn to verify the prognostic value of 6-OMAGs. Screened by univariate and multivariate Cox regression analysis, 3 (age, cancer status, primary therapy outcome) of 5 clinicopathological characteristics were used to construct the nomogram combined with risk score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We constructed an ovarian cancer prognostic model related to omentum metastasis composed of 6-OMAGs and 3 clinicopathological features and analyzed the potential mechanism of these 6-OMAGs in ovarian cancer omental metastasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-022-01059-0","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T18:37:51Z","timestamp":1669315071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq"],"prefix":"10.1186","volume":"15","author":[{"given":"Dongni","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heting","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397:2182\u201393.","journal-title":"Lancet"},{"key":"1059_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284\u201396.","journal-title":"CA Cancer J Clin"},{"key":"1059_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","volume":"26","author":"S Pradeep","year":"2014","unstructured":"Pradeep S, Kim SW, Wu SY, et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell. 2014;26:77\u201391.","journal-title":"Cancer Cell"},{"key":"1059_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1084\/jem.20181170","volume":"216","author":"W Lee","year":"2019","unstructured":"Lee W, Ko SY, Mohamed MS, et al. Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum. J Exp Med. 2019;216:176\u201394.","journal-title":"J Exp Med"},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"viii30","DOI":"10.1093\/annonc\/mdx449","volume":"28","author":"MA Bookman","year":"2017","unstructured":"Bookman MA, Okamoto A, Stuart G, et al. Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference. Ann Oncol. 2017;28:viii30\u20135.","journal-title":"Ann Oncol"},{"key":"1059_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-017-0614-y","volume":"16","author":"G Girolimetti","year":"2017","unstructured":"Girolimetti G, De Iaco P, Procaccini M, et al. Mitochondrial DNA sequencing demonstrates clonality of peritoneal implants of borderline ovarian tumors. Mol Cancer. 2017;16:47.","journal-title":"Mol Cancer"},{"key":"1059_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cmet.2018.08.007","volume":"29","author":"M Curtis","year":"2019","unstructured":"Curtis M, Kenny HA, Ashcroft B, et al. Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. Cell Metab. 2019;29:141\u201355 e149.","journal-title":"Cell Metab"},{"key":"1059_CR8","doi-asserted-by":"publisher","first-page":"e20191869","DOI":"10.1084\/jem.20191869","volume":"217","author":"A Etzerodt","year":"2020","unstructured":"Etzerodt A, Moulin M, Doktor TK, et al. Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer. J Exp Med. 2020;217:e20191869.","journal-title":"J Exp Med"},{"key":"1059_CR9","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.cell.2018.03.073","volume":"173","author":"AW Zhang","year":"2018","unstructured":"Zhang AW, McPherson A, Milne K, et al. Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer. Cell. 2018;173:1755\u201369 e1722.","journal-title":"Cell"},{"key":"1059_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-017-0742-4","volume":"16","author":"Q Liu","year":"2017","unstructured":"Liu Q, Zhang H, Jiang X, et al. Factors involved in cancer metastasis: a better understanding to \u201cseed and soil\u201d hypothesis. Mol Cancer. 2017;16:176.","journal-title":"Mol Cancer"},{"key":"1059_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41581-018-0021-7","volume":"14","author":"SS Potter","year":"2018","unstructured":"Potter SS. Single-cell RNA sequencing for the study of development, physiology and disease. Nat Rev Nephrol. 2018;14:479\u201392.","journal-title":"Nat Rev Nephrol"},{"key":"1059_CR12","doi-asserted-by":"publisher","first-page":"109165","DOI":"10.1016\/j.celrep.2021.109165","volume":"35","author":"S Olalekan","year":"2021","unstructured":"Olalekan S, Xie B, Back R, et al. Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics. Cell Rep. 2021;35:109165.","journal-title":"Cell Rep"},{"key":"1059_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/nyas.14748","volume":"1512","author":"C Liu","year":"2022","unstructured":"Liu C, Zhang Y, Li X, Wang D. Ovarian cancer-specific dysregulated genes with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation. Ann N Y Acad Sci. 2022;1512:154\u201373.","journal-title":"Ann N Y Acad Sci"},{"key":"1059_CR14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.annonc.2020.05.019","volume":"31","author":"J Millstein","year":"2020","unstructured":"Millstein J, Budden T, Goode EL, et al. Prognostic gene expression signature for high-grade serous ovarian cancer. Ann Oncol. 2020;31:1240\u201350.","journal-title":"Ann Oncol"},{"key":"1059_CR15","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387 e3529.","journal-title":"Cell"},{"key":"1059_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163\u201372.","journal-title":"Nat Immunol"},{"key":"1059_CR17","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.stem.2017.03.007","volume":"20","author":"L Li","year":"2017","unstructured":"Li L, Dong J, Yan L, et al. Single-Cell RNA-Seq Analysis Maps Development of Human Germline Cells and Gonadal Niche Interactions. Cell Stem Cell. 2017;20:858-873 e854.","journal-title":"Cell Stem Cell"},{"key":"1059_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ygyno.2017.01.015","volume":"144","author":"BJ Winterhoff","year":"2017","unstructured":"Winterhoff BJ, Maile M, Mitra AK, et al. Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells. Gynecol Oncol. 2017;144:598\u2013606.","journal-title":"Gynecol Oncol"},{"key":"1059_CR19","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41467-017-02289-3","volume":"8","author":"M Schelker","year":"2017","unstructured":"Schelker M, Feau S, Du J, et al. Estimation of immune cell content in tumour tissue using single-cell RNA-seq data. Nat Commun. 2017;8:2032.","journal-title":"Nat Commun"},{"key":"1059_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/cas.12691","volume":"106","author":"J Neradil","year":"2015","unstructured":"Neradil J, Veselska R. Nestin as a marker of cancer stem cells. Cancer Sci. 2015;106:803\u201311.","journal-title":"Cancer Sci"},{"key":"1059_CR21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14:979\u201382.","journal-title":"Nat Methods"},{"key":"1059_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"1059_CR23","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"1059_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","volume":"32","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Shih J, Yau C, et al. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell. 2017;32:204\u201320 e215.","journal-title":"Cancer Cell"},{"key":"1059_CR25","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"1059_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"1059_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1467-9868.2011.01004.x","volume":"74","author":"R Tibshirani","year":"2012","unstructured":"Tibshirani R, Bien J, Friedman J, et al. Strong rules for discarding predictors in lasso-type problems. J R Stat Soc Series B Stat Methodol. 2012;74:245\u201366.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"1059_CR28","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173\u201380.","journal-title":"Lancet Oncol"},{"key":"1059_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"1059_CR30","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/cancers12071788","volume":"12","author":"J Wei","year":"2020","unstructured":"Wei J, Huang K, Chen Z, et al. Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data. Cancers (Basel). 2020;12:1788.","journal-title":"Cancers (Basel)"},{"key":"1059_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jane-Valbuena J, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"1059_CR32","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui C, Wang J, Fagerberg E, et al. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell. 2021;184:6101-6118 e6113.","journal-title":"Cell"},{"key":"1059_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2020;15:123\u201347.","journal-title":"Annu Rev Pathol"},{"key":"1059_CR34","doi-asserted-by":"publisher","first-page":"759497","DOI":"10.3389\/fonc.2021.759497","volume":"11","author":"CH Chang","year":"2021","unstructured":"Chang CH, Shih AC, Chang YH, et al. The Prognostic Significance of PD1 and PDL1 Gene Expression in Lung Cancer: A Meta-Analysis. Front Oncol. 2021;11:759497.","journal-title":"Front Oncol"},{"key":"1059_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","volume":"20","author":"DJ Cheon","year":"2014","unstructured":"Cheon DJ, Tong Y, Sim MS, et al. A collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer. Clin Cancer Res. 2014;20:711\u201323.","journal-title":"Clin Cancer Res"},{"key":"1059_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41419-019-2016-0","volume":"10","author":"CW Su","year":"2019","unstructured":"Su CW, Chang YC, Chien MH, et al. Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis. Cell Death Dis. 2019;10:793.","journal-title":"Cell Death Dis"},{"key":"1059_CR37","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/jcmm.15911","volume":"26","author":"W Li","year":"2022","unstructured":"Li W, Song YY, Rao T, et al. CircCSNK1G3 up-regulates miR-181b to promote growth and metastasis via TIMP3-mediated epithelial to mesenchymal transitions in renal cell carcinoma. J Cell Mol Med. 2022;26:1729\u201341.","journal-title":"J Cell Mol Med"},{"key":"1059_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cac2.12274","volume":"42","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen W, Zuo L, et al. The Fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Commun (Lond). 2022;42:245\u201365.","journal-title":"Cancer Commun (Lond)"},{"key":"1059_CR39","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1158\/1078-0432.CCR-12-0566","volume":"18","author":"TL Whiteside","year":"2012","unstructured":"Whiteside TL, Ferrone S. For breast cancer prognosis, immunoglobulin kappa chain surfaces to the top. Clin Cancer Res. 2012;18:2417\u20139.","journal-title":"Clin Cancer Res"},{"key":"1059_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13048-016-0232-0","volume":"9","author":"S Lundgren","year":"2016","unstructured":"Lundgren S, Berntsson J, Nodin B, et al. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer. J Ovarian Res. 2016;9:21.","journal-title":"J Ovarian Res"},{"key":"1059_CR41","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-11-2210","volume":"18","author":"M Schmidt","year":"2012","unstructured":"Schmidt M, Hellwig B, Hammad S, et al. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin kappa C as a compatible prognostic marker in human solid tumors. Clin Cancer Res. 2012;18:2695\u2013703.","journal-title":"Clin Cancer Res"},{"key":"1059_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molcel.2009.03.006","volume":"34","author":"JR Warner","year":"2009","unstructured":"Warner JR, McIntosh KB. How common are extraribosomal functions of ribosomal proteins? Mol Cell. 2009;34:3\u201311.","journal-title":"Mol Cell"},{"key":"1059_CR43","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/onc.2013.153","volume":"33","author":"F Loreni","year":"2014","unstructured":"Loreni F, Mancino M, Biffo S. Translation factors and ribosomal proteins control tumor onset and progression. how? Oncogene. 2014;33:2145\u201356.","journal-title":"how? Oncogene"},{"key":"1059_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ajhg.2009.12.015","volume":"86","author":"L Doherty","year":"2010","unstructured":"Doherty L, Sheen MR, Vlachos A, et al. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am J Hum Genet. 2010;86:222\u20138.","journal-title":"Am J Hum Genet"},{"key":"1059_CR45","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3389\/fonc.2020.01730","volume":"10","author":"C Li","year":"2020","unstructured":"Li C, Ge M, Chen D, et al. RPL21 siRNA Blocks Proliferation in Pancreatic Cancer Cells by Inhibiting DNA Replication and Inducing G1 Arrest and Apoptosis. Front Oncol. 2020;10:1730.","journal-title":"Front Oncol"},{"key":"1059_CR46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1039\/C6MB00615A","volume":"13","author":"S Suman","year":"2017","unstructured":"Suman S, Mishra A, Kulshrestha A. A systems approach for the elucidation of crucial genes and network constituents of cervical intraepithelial neoplasia 1 (CIN1). Mol Biosyst. 2017;13:549\u201355.","journal-title":"Mol Biosyst"},{"key":"1059_CR47","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1182\/blood-2015-07-656678","volume":"127","author":"T Bedekovics","year":"2016","unstructured":"Bedekovics T, Hussain S, Feldman AL, Galardy PJ. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma. Blood. 2016;127:1564\u201374.","journal-title":"Blood"},{"key":"1059_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1476-4598-10-129","volume":"10","author":"R Ummanni","year":"2011","unstructured":"Ummanni R, Jost E, Braig M, et al. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation. Mol Cancer. 2011;10:129.","journal-title":"Mol Cancer"},{"key":"1059_CR49","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.7150\/thno.42096","volume":"10","author":"X Ding","year":"2020","unstructured":"Ding X, Gu Y, Jin M, et al. The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase. Theranostics. 2020;10:6048\u201360.","journal-title":"Theranostics"},{"key":"1059_CR50","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-19-1373","volume":"26","author":"S Liu","year":"2020","unstructured":"Liu S, Gonzalez-Prieto R, Zhang M, et al. Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFbeta-Induced Breast Cancer Metastasis. Clin Cancer Res. 2020;26:1460\u201373.","journal-title":"Clin Cancer Res"},{"key":"1059_CR51","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13046-018-0931-z","volume":"37","author":"Y Gu","year":"2018","unstructured":"Gu Y, Lv F, Xue M, et al. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation. J Exp Clin Cancer Res. 2018;37:258.","journal-title":"J Exp Clin Cancer Res"},{"key":"1059_CR52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/CBM-190528","volume":"26","author":"DW Gutkin","year":"2019","unstructured":"Gutkin DW, Shurin MR, El Azher MA, et al. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. Cancer Biomark. 2019;26:471\u20139.","journal-title":"Cancer Biomark"},{"key":"1059_CR53","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1158\/1541-7786.MCR-20-0883","volume":"19","author":"A Tangri","year":"2021","unstructured":"Tangri A, Lighty K, Loganathan J, et al. Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-grade Serous Ovarian Carcinoma. Mol Cancer Res. 2021;19:1168\u201381.","journal-title":"Mol Cancer Res"},{"key":"1059_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2020.02.021","volume":"150","author":"MA Cucci","year":"2020","unstructured":"Cucci MA, Grattarola M, Dianzani C, et al. Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism. Free Radic Biol Med. 2020;150:125\u201335.","journal-title":"Free Radic Biol Med"},{"key":"1059_CR55","doi-asserted-by":"publisher","first-page":"662","DOI":"10.7150\/jca.6641","volume":"4","author":"C Jin","year":"2013","unstructured":"Jin C, Yu W, Lou X, et al. UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance. J Cancer. 2013;4:662\u201370.","journal-title":"J Cancer"},{"key":"1059_CR56","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/0008-5472.CAN-10-2294","volume":"71","author":"ZJ Sahab","year":"2011","unstructured":"Sahab ZJ, Hall MD, Me Sung Y, et al. Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the alpha-tubulin tyrosination cycle. Cancer Res. 2011;71:1219\u201328.","journal-title":"Cancer Res"},{"key":"1059_CR57","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/s41416-020-0798-6","volume":"122","author":"L Peterfi","year":"2020","unstructured":"Peterfi L, Banyai D, Yusenko MV, et al. Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma. Br J Cancer. 2020;122:1818\u201324.","journal-title":"Br J Cancer"},{"key":"1059_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13046-017-0634-x","volume":"36","author":"H Huebner","year":"2017","unstructured":"Huebner H, Strick R, Wachter DL, et al. Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma. J Exp Clin Cancer Res. 2017;36:165.","journal-title":"J Exp Clin Cancer Res"},{"key":"1059_CR59","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3892\/ol.2017.5612","volume":"13","author":"Y Li","year":"2017","unstructured":"Li Y, Rong G, Kang H. Taxotere-induced elevated expression of IL8 in carcinoma-associated fibroblasts of breast invasive ductal cancer. Oncol Lett. 2017;13:1856\u201360.","journal-title":"Oncol Lett"},{"key":"1059_CR60","doi-asserted-by":"publisher","first-page":"e70960","DOI":"10.1371\/journal.pone.0070960","volume":"8","author":"G Rong","year":"2013","unstructured":"Rong G, Kang H, Wang Y, et al. Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs). PLoS ONE. 2013;8:e70960.","journal-title":"PLoS ONE"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-01059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-022-01059-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-01059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T18:44:30Z","timestamp":1669315470000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-022-01059-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1186\/s13048-022-01059-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}